Midtown Tennessee Oncology — Nashville, Tennessee

Midtown Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Midtown Tennessee Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC.

Sponsors: Genmab.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midtown Tennessee Oncology?

Midtown Tennessee Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midtown Tennessee Oncology conducted?

Midtown Tennessee Oncology has 1 clinical trials on record, with 1 currently active. Their work covers PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC.

Is Midtown Tennessee Oncology accredited by Crixeo Health?

Midtown Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midtown Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.